Evidence map›Paper›PMID 39981031›Full record

ArticleCase reports in neurology

Botulism: An Overlooked Cause of Bulbar Weakness in Intensive Care - A Case Report.

Louise Adams, Simon Lamquet, Julie Linussio, Tom Van Nieuwenhuysen, Alexandra Vodolazkaia, Marina Mukovnikova, Heleen Parmentier, Sarah Herdewyn

Abstract readCase Reports
In one paragraph

Article in Case reports in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Louise AdamsDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Simon LamquetDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Julie LinussioNational Reference Centre for Clostridium botulinum, Clostridium perfringens and Clostridium tetani, Sciensano, Brussels, Belgium.
Tom Van NieuwenhuysenNational Reference Centre for Clostridium botulinum, Clostridium perfringens and Clostridium tetani, Sciensano, Brussels, Belgium.
Alexandra VodolazkaiaNational Reference Centre for Clostridium botulinum, Clostridium perfringens and Clostridium tetani, Sciensano, Brussels, Belgium.
Marina MukovnikovaNational Reference Centre for Clostridium botulinum, Clostridium perfringens and Clostridium tetani, Sciensano, Brussels, Belgium.
Heleen ParmentierDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Sarah HerdewynDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Botulism is a rare but potentially life-threatening syndrome caused by botulinum neurotoxin. The classic presentation of botulism is the acute onset of bilateral cranial neuropathies associated with symmetric descending weakness. The antitoxin is the main therapeutic option for botulism, in addition to supportive care with intubation and mechanical ventilation when necessary. The outcome is usually favorable, with a slow but full neurological recovery. This case presents a difficult diagnosis of the sporadic form of adult intestinal toxemia, with a delayed diagnosis. Case Presentation: We report a 64-year-old patient who presented in a confused state with weakness in the limbs, bilateral ptosis, and dysarthria. Because of disease progression with respiratory compromise, the patient was transferred to the intensive care unit (ICU) and intubated. The diagnosis of botulism was eventually confirmed in the stool 46 days after presentation. By the end of follow-up, the patient still received rehabilitation. The outcome was good, except for the concomitant neurodegenerative disorder with the need for institutionalization at a residential care center. Conclusion: This case report illustrates the difficulties in diagnosing a patient with botulism in the ICU, especially if associated with comorbidities. Delayed diagnosis and misdiagnosis are common because of the rarity of the disease and overlapping signs and symptoms with other neurological diseases. Increasing the awareness of this disease is important to prevent mortality and morbidity.

Indexed as

BotulismBulbar weaknessCase reportClostridium botulinum

Identifiers

PMID39981031
PMCPMC11781810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.